Olanzapine ratio, a new generic in the treatment of schizophrenia, manic episode and prevention of relapse in bipolar disorder.

-Olanzapine is an antipsychotic, antimaníaco and stabilizing agent of the mood

-schizophrenia is a mental disorder suffered by 400,000 Spanish, roughly one for every hundred people. Also, one in every 100 adults have bipolar disorder (formerly known as manic-depressive disorder) at some point in their life.

-compliance with treatment in these patients helps to achieve a significant improvement in the quality of life

Madrid, 2011-October ratiopharm, has made available to health professionals, olanzapine ratio, a new generic antipsychotic atypical.

The olanzapine in the treatment of schizophrenia. It is also effective to maintain the improvement in patients who have responded to an initial course of treatment. Also, this medication is indicated for the treatment of manic episode moderate or severe, and in the prevention of relapses in patients with bipolar disorder with manic episode has responded to treatment with olanzapine.

Olanzapine ratiose presented in tablets EFG (2.5 mg, 5 mg, 7.5 mg and 10 mg) and compressed bucodispersables EFG (5 mg and 10 mg). This new generic of ratiopharm, can be administered with or without food because food does not affect its absorption. Likewise, the compressed bucodispersables, can be used as an alternative to the pills.

Olanzapine is an antipsychotic, antimaníaco and stabilizing agent of the mind, also contributes to a better achievement thanks to its bucodispersable formulation. Also, various studies show the eficicacia of olanzapine in the treatment of schizophrenia, manic episode and prevention of relapse in bipolar disorder.

Compliance helps to improve the quality of life of the patient

Mental disorders are in our country, as in the rest of the Western world, a very common cause of disability, loss of quality of life, suffering, social isolation, stigmatization, physical sobremorbilidad and/or mortality for suicidal behavior. In our country, 9% of the population suffers from some mental disorder and more than 15% it will throughout his life.

Schizophrenia is a mental disorder suffered by 400,000 Spanish, roughly one for every hundred people. The World Health Organization (who) estimates that each year are diagnosed between 15 and 30 new cases per 100,000 inhabitants. One in every 100 adults also has bipolar disorder at some point in his life.

The lack of adherence to treatment and the total or partial abandonment of the medication is a major problem in patients with psychiatric illnesses. The consequences of therapeutic failure in these patients are very important as it increases the risk of a relapse / hospital admission and the duration of hospital stay.

Compliance with treatment in patients with schizophrenia and bipolar disorder help achieve a significant improvement in the quality of life.

Presentations olanzapine ratio

Olanzapine 2.5 compressed EFG 28 mg ratio

olanzapine ratio 5 compressed EFG 28 mg

olanzapine ratio 7.5 mg EFG 56 compressed

olanzapine ratio 10 mg 28 EFG compressed

olanzapine ratio 10 mg 56 EFG compressed

olanzapine 5 mg 28 compressed bucodispersables ratio

olanzapine ratio 10 mg 28 compressed bucodispersables

olanzapine ratio 10 mg 56 compressed bucodispersables